10/26/2026
John J. Giordano's journey from addiction to advocacy
At 80, Giordano champions ibogaine for addiction recovery, leveraging personal history.
Topic archive
3 stories
10/26/2026
At 80, Giordano champions ibogaine for addiction recovery, leveraging personal history.
8/26/2026
The move promotes open science and could influence future psychedelic research.
8/21/2026
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.